Hepion Pharmaceuticals (HEPA) Institutional Ownership → get a piece of the profit from this land (From True Market Insiders) (Ad) Free HEPA Stock Alerts $1.30 +0.06 (+4.84%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.05MNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023 Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022Virtu Financial LLC67,802$34K0.0%+195.6%0.089% 10/13/2022PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022 Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/4/2022 Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% 11/10/2021PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021 BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021 PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021 Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021 Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021 Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021 State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021 Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021 Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021 Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021 BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021 Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021 Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021 McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021 Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021 Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021 Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021 Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021 UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021 Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021 GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021 BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021 Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% 5/4/2021 Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% The CHIPS Act Motherlode (Ad)If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024.4/26/2021 McAdam LLC36,641$67K0.0%N/A0.048% 2/17/2021 Worth Venture Partners LLC233,947$512K0.4%N/A2.592% 2/16/2021 Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/12/2021Prospera Financial Services Inc39,300$86K0.0%N/A0.435% 2/11/2021 Northern Trust Corp63,402$139K0.0%N/A0.703% 2/10/2021 Renaissance Technologies LLC329,022$721K0.0%N/A3.646% 2/9/2021 Perkins Capital Management Inc.150,000$329K0.2%N/A1.662% 2/9/2021 Bank of New York Mellon Corp40,945$90K0.0%N/A0.454% 2/5/2021 BlackRock Inc.1,194,434$2.62M0.0%+1,867.1%13.235% 2/4/2021 GSA Capital Partners LLP89,067$195K0.0%N/A0.987% 1/19/2021 Allen Capital Group LLC23,685$52K0.0%N/A0.262% 11/16/2020 ExodusPoint Capital Management LP11,632$36K0.0%N/A0.129% 5/15/2020 Sabby Management LLC72,575$128K0.1%N/A0.825% (Data available from 1/1/2016 forward) HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($1.35M), Ikarian Capital LLC ($235K), and PVG Asset Management Corp ($55K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($418K), PVG Asset Management Corp ($107.92K), and Virtu Financial LLC ($77.20K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 603,118 shares in the last 24 months. This purchase volume represents approximately $4.10M in transactions. Which Hepion Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Hepion Pharmaceuticals stock in the last 24 months: Ikarian Capital LLC ($171.95K). How much institutional selling is happening at Hepion Pharmaceuticals? Institutional investors have sold a total of 171,948 shares in the last 24 months. This volume of shares sold represents approximately $1.97M in transactions. Related Companies: CVKD Major Shareholders VCNX Major Shareholders VIRI Major Shareholders EFTR Major Shareholders CANF Major Shareholders BFRI Major Shareholders PULM Major Shareholders ASLN Major Shareholders BNOX Major Shareholders VAXX Major Shareholders This page (NASDAQ:HEPA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
